Literature DB >> 21698349

Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve.

Kadriye Orta Kilickesmez1, Okay Abaci, Cuneyt Kocas, Ahmet Yildiz, Aysem Kaya, Baris Okcun, Serdar Kucukoglu.   

Abstract

Predictors of aortic dilatation are not well described in patients with bicuspid aortic valves (BAV). This study sought to examine the relationship between proximal aortic dilatation and matrix metalloproteinase-9 (MMP-9) and alpha 1-antitrypsin (α1AT) levels in patients with BAV. All patients underwent echocardiography using a standard protocol, and aortic measurements were taken in end-diastole. We studied 82 patients with BAV and categorized them into two groups according to aortic dimensions corrected for body surface area and age. The plasma level of α1AT was routinely determined using a BN ProSpec analyzer (Siemens Healthcare Diagnostics, Marburg, Germany), and that of MMP-9 were determined by ELISA (RayBiotech Inc. Norcross, GA, USA). Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS; SPSS Inc., Chicago, IL, USA) software for Windows version 12. This study included patients with BAV with no or mild valvular impairment. There were no significant differences between groups in terms of gender, body surface area, associated hypertension, diabetes mellitus, hyperlipidemia, or smoking. The mean ascending aortic diameter was 4.38 ± 0.5 mm in group 1 and 3.34 ± 0.35 mm in group 2 (p < 0.001). Plasma concentration of α1AT in patients with ascending aortic dilatation was significantly lower than that in the non-dilated group (1.32 ± 0.27 and 1.49 ± 0.25 g/l, respectively; p = 0.005). However, no significant difference was found in the MMP-9 level between the two groups (336.49 ± 233.11 and 336.39 ± 268.072 pg/ml, respectively; p = 0.96). We observed a significantly negative correlation between ascending aortic diameter and α1AT level (r = -0.300, p = 0.006) and a positive correlation between ascending aortic diameter and age (r = 0.413, p < 0.001). No significant correlation was found between plasma MMP-9 concentration and ascending aortic diameter (r = -0.008, p = 0.94). A multiple linear regression analysis was performed, including age, α1AT level, MMP-9 level, and left ventricular diastolic diameter. In this analysis, α1AT level and age were the independent predictors of aortic dilatation (p = 0.03 and p = 0.02, respectively).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698349     DOI: 10.1007/s00380-011-0161-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  44 in total

1.  Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction.

Authors:  Moreno Cecconi; Marcello Manfrin; Alessandra Moraca; Raffaele Zanoli; Pier Luigi Colonna; Maria Grazia Bettuzzi; Stefano Moretti; Domenico Gabrielli; Gian Piero Perna
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

Review 2.  Left ventricular outflow obstruction: subaortic stenosis, bicuspid aortic valve, supravalvar aortic stenosis, and coarctation of the aorta.

Authors:  Jamil Aboulhosn; John S Child
Journal:  Circulation       Date:  2006-11-28       Impact factor: 29.690

3.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1970-07       Impact factor: 2.778

4.  Aortic medial changes associated with bicuspid aortic valve: myth or reality?

Authors:  J L Parai; R G Masters; V M Walley; W A Stinson; J P Veinot
Journal:  Can J Cardiol       Date:  1999-11       Impact factor: 5.223

Review 5.  The bicuspid aortic valve.

Authors:  Alan C Braverman; Hasan Güven; Michael A Beardslee; Majesh Makan; Andrew M Kates; Marc R Moon
Journal:  Curr Probl Cardiol       Date:  2005-09       Impact factor: 5.200

6.  Abdominal aortic aneurysms and alpha 1-antitrypsin deficiency.

Authors:  A N Elzouki; S Eriksson
Journal:  J Intern Med       Date:  1994-11       Impact factor: 8.989

Review 7.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

8.  Bicuspid aortic valve: abnormal aortic elastic properties.

Authors:  Stefano Nistri; Maria Domenica Sorbo; Cristina Basso; Gaetano Thiene
Journal:  J Heart Valve Dis       Date:  2002-05

9.  Search for serum biomarkers associated with abdominal aortic aneurysm growth--a pilot study.

Authors:  M Vega de Céniga; M Esteban; J M Quintana; A Barba; L Estallo; N de la Fuente; B Viviens; J L Martin-Ventura
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-12-25       Impact factor: 7.069

10.  Elastin metabolism of the infrarenal aorta.

Authors:  J R Cohen; C Mandell; J B Chang; L Wise
Journal:  J Vasc Surg       Date:  1988-02       Impact factor: 4.268

View more
  10 in total

1.  Progressive aortic dilation and aortic stiffness in children with repaired tetralogy of Fallot.

Authors:  Mitsuru Seki; Clara Kurishima; Hirofumi Saiki; Satoshi Masutani; Hirokazu Arakawa; Masanori Tamura; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2013-02-24       Impact factor: 2.037

2.  Anti-correlation between longevity gene SirT1 and Notch signaling in ascending aorta biopsies from patients with bicuspid aortic valve disease.

Authors:  Sergio Sciacca; Michele Pilato; Gianluigi Mazzoccoli; Valerio Pazienza; Manlio Vinciguerra
Journal:  Heart Vessels       Date:  2012-02-28       Impact factor: 2.037

3.  Subtypes of bicuspid aortic valves in coarctation of the aorta.

Authors:  Daniel Rinnström; Karl Gunnar Engström; Bengt Johansson
Journal:  Heart Vessels       Date:  2013-06-08       Impact factor: 2.037

4.  Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome.

Authors:  Munenori Takata; Eisuke Amiya; Masafumi Watanabe; Kazuko Omori; Yasushi Imai; Daishi Fujita; Hiroshi Nishimura; Masayoshi Kato; Tetsuro Morota; Kan Nawata; Atsuko Ozeki; Aya Watanabe; Shuichi Kawarasaki; Yumiko Hosoya; Tomoko Nakao; Koji Maemura; Ryozo Nagai; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2013-07-14       Impact factor: 2.037

5.  Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.

Authors:  Yongshi Wang; Boting Wu; Lili Dong; Chunsheng Wang; Xiaolin Wang; Xianhong Shu
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

6.  Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease.

Authors:  Oliver J Harrison; Felino Cagampang; Sunil K Ohri; Christopher Torrens; Kareem Salhiyyah; Amit Modi; Narain Moorjani; Anthony D Whetton; Paul A Townsend
Journal:  J Cardiothorac Surg       Date:  2018-06-22       Impact factor: 1.637

Review 7.  Novel Approaches for BAV Aortopathy Prediction-Is There a Need for Cohort Studies and Biomarkers?

Authors:  Evaldas Girdauskas; Johannes Petersen; Niklas Neumann; Shiho Naito; Tatiana Gross; Annika Jagodzinski; Hermann Reichenspurner; Tanja Zeller
Journal:  Biomolecules       Date:  2018-07-19

Review 8.  Causes, Diagnosis, Risk Stratification and Treatment of Bicuspid Aortic Valve Disease: An Updated Review.

Authors:  Stefanos Sakellaropoulos; Muhemin Mohammed; Stefano Svab; Dimitra Lekaditi; Panagiotis Sakellaropoulos; Andreas Mitsis
Journal:  Cardiol Res       Date:  2020-06-03

9.  Oxidative stress parameters in patients with ascending aortic dilatation

Authors:  Mehmet Erdoğan; Melike Polat; Muhammet Cihat Çelik; Selçuk Öztürk; Serdal Baştuğ; Yunus Emre Özbebek; Salim Neşelioğlu; Murat Akçay
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

10.  Ascending aortic wall cohesion: comparison of bicuspid and tricuspid valves.

Authors:  Jaroslav Benedik; Kevin Pilarczyk; Daniel Wendt; Jiri Indruch; Radek Flek; Konstantinos Tsagakis; Savvas Alaeddine; Heinz Jakob
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.